| P2093 | author name string | Cattan A | |
| | Marechal F | |
| | Desoize B | |
| P2860 | cites work | Reporting results of cancer treatment | Q29620070 |
| | The clinical pharmacology of etoposide and teniposide | Q39658304 |
| | Anticancer drug pharmacodynamics | Q39819996 |
| | Superiority of perfusion over bolus administration in cancer chemotherapy: proposition of a compartmental model | Q41315749 |
| | A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study | Q44583571 |
| | Adaptive control of etoposide administration: impact of interpatient pharmacodynamic variability. | Q52537614 |
| | Etoposide: a pharmacokinetic profile including an assessment of bioavailability | Q61868437 |
| | Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial | Q69065015 |
| | Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function | Q69485233 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| | etoposide | Q418817 |
| P304 | page(s) | 840-841 | |
| P577 | publication date | 1990-11-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Clinical pharmacokinetics of etoposide during 120 hours continuous infusions in solid tumours | |
| P478 | volume | 62 | |